ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA January 2019.pdf

Drug Safety Update MHRA January 2019.pdf
Summary: Tapentadol: risk of seizures & reports of serotonin syndrome when co-administered with other medicines.Ipilimumab: reports of cytomegalovirus GU infection or reactivation.
File Size: 366KB
File Type: application/pdf
Created: 11 January 2019
Last Modified: 18 February 2019